Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Valproic acid and rapamycin protect hair follicle stem cells from damage by activating a protective pathway.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

The plant hormone auxin activates the TOR pathway, affecting gene expression related to growth and cell size.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Over-expression of Sp2 can lead to cancer by preventing proper stem cell differentiation.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Mutations in the POC1A gene can cause a unique form of extreme insulin resistance and short stature.

EGFR helps control how hair grows and forms without needing p53 protein.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Inhibiting ODC can prevent UV-induced skin cancer.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.